136 related articles for article (PubMed ID: 26941183)
21. Intratumoural heterogeneity may hinder precision medicine strategies in patients with clear cell renal cell carcinoma.
Raspollini MR; Montagnani I; Montironi R; Castiglione F; Martignoni G; Cheng L; Lopez-Beltran A
J Clin Pathol; 2018 May; 71(5):467-471. PubMed ID: 29317515
[TBL] [Abstract][Full Text] [Related]
22. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.
Kim SS; Cho YM; Kim GH; Kee KH; Kim HS; Kim KM; Kim JH; Choi C
Mod Pathol; 2020 Apr; 33(4):690-699. PubMed ID: 31953522
[TBL] [Abstract][Full Text] [Related]
23. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
[TBL] [Abstract][Full Text] [Related]
24. Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 cases.
Rao P; Monzon F; Jonasch E; Matin SF; Tamboli P
Hum Pathol; 2014 Sep; 45(9):1966-72. PubMed ID: 25081542
[TBL] [Abstract][Full Text] [Related]
25. Clear cell papillary renal cell carcinoma: Incidence, morphological features, immunohistochemical profile, and biologic behavior: A single institution study.
Alexiev BA; Drachenberg CB
Pathol Res Pract; 2014 Apr; 210(4):234-41. PubMed ID: 24485757
[TBL] [Abstract][Full Text] [Related]
26. Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study.
Kuroda N; Shiotsu T; Kawada C; Shuin T; Hes O; Michal M; Ohe C; Mikami S; Pan CC
Ann Diagn Pathol; 2011 Aug; 15(4):282-5. PubMed ID: 20952286
[TBL] [Abstract][Full Text] [Related]
27. Analysis of clinicopathological and molecular features of ELOC(TCEB1)-mutant renal cell carcinoma.
Wang Y; Zhao P; Wang L; Wang J; Ji X; Li Y; Shi H; Li Y; Zhang W; Jiang Y
Pathol Res Pract; 2022 Jul; 235():153960. PubMed ID: 35653922
[TBL] [Abstract][Full Text] [Related]
28. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
[TBL] [Abstract][Full Text] [Related]
29. Cystic clear cell papillary renal cell carcinoma: is it related to multilocular clear cell cystic neoplasm of low malignant potential?
Brimo F; Atallah C; Li G; Srigley JR
Histopathology; 2016 Apr; 68(5):666-72. PubMed ID: 26256827
[TBL] [Abstract][Full Text] [Related]
30. Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases.
Adam J; Couturier J; Molinié V; Vieillefond A; Sibony M
Histopathology; 2011 Jun; 58(7):1064-71. PubMed ID: 21707708
[TBL] [Abstract][Full Text] [Related]
31. Unilateral synchronous papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma: a case report with KRAS and PIK3CA mutations.
Lee HJ; Shin DH; Park JY; Kim SY; Hwang CS; Lee JH; Kim JY; Sol MY; Nam JK
Diagn Pathol; 2020 Oct; 15(1):123. PubMed ID: 33023600
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis A virus cellular receptor 1/kidney injury molecule-1 is a susceptibility gene for clear cell renal cell carcinoma and hepatitis A virus cellular receptor/kidney injury molecule-1 ectodomain shedding a predictive biomarker of tumour progression.
Cuadros T; Trilla E; Vilà MR; de Torres I; Vilardell J; Messaoud NB; Salcedo M; Sarró E; López-Hellin J; Blanco A; Mir C; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
Eur J Cancer; 2013 May; 49(8):2034-47. PubMed ID: 23352434
[TBL] [Abstract][Full Text] [Related]
33. Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma.
Petersson F; Grossmann P; Hora M; Sperga M; Montiel DP; Martinek P; Gutierrez ME; Bulimbasic S; Michal M; Branzovsky J; Hes O
Hum Pathol; 2013 Jul; 44(7):1412-20. PubMed ID: 23434146
[TBL] [Abstract][Full Text] [Related]
34. Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.
Tian X; Xu WH; Wu JL; Gan HL; Wang HK; Gu WJ; Qu YY; Zhang HL; Ye DW
Pathol Oncol Res; 2021; 27():1609809. PubMed ID: 34512202
[TBL] [Abstract][Full Text] [Related]
35. Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma.
Tran T; Jones CL; Williamson SR; Eble JN; Grignon DJ; Zhang S; Wang M; Baldridge LA; Wang L; Montironi R; Scarpelli M; Tan PH; Simper NB; Comperat E; Cheng L
Histopathology; 2016 May; 68(6):850-7. PubMed ID: 26310887
[TBL] [Abstract][Full Text] [Related]
36. Alpha-methyl CoA racemase (AMACR) reactivity across the spectrum of clear cell renal cell neoplasms.
Rotterova P; Alaghehbandan R; Skopal J; Rogala J; Slisarenko M; Strakova Peterikova A; Michalova K; Montiel DP; Farcas M; Ulamec M; Stransky P; Fiala O; Pitra T; Hora M; Michal M; Pivovarcikova K; Hes O
Ann Diagn Pathol; 2024 Aug; 71():152297. PubMed ID: 38579443
[TBL] [Abstract][Full Text] [Related]
37. Synchronous clear cell renal cell carcinoma and multilocular cystic renal cell neoplasia of low malignant potential: A clinico-pathologic and molecular study.
Raspollini MR; Castiglione F; Cheng L; Montironi R; Lopez-Beltran A
Pathol Res Pract; 2016 May; 212(5):471-4. PubMed ID: 26874573
[TBL] [Abstract][Full Text] [Related]
38. Histomorphometric and Immunohistochemical Diagnosis of Renal Cell Carcinoma: Review Article.
Deka D; Chakravarty M
Mymensingh Med J; 2024 Apr; 33(2):636-642. PubMed ID: 38557550
[TBL] [Abstract][Full Text] [Related]
39. Papillary cystadenoma of the epididymis and broad ligament: morphologic and immunohistochemical overlap with clear cell papillary renal cell carcinoma.
Cox R; Vang R; Epstein JI
Am J Surg Pathol; 2014 May; 38(5):713-8. PubMed ID: 24441657
[TBL] [Abstract][Full Text] [Related]
40. Metastasis from papillary renal cell carcinoma masquerading as primary ovarian clear cell tumor.
Stolnicu S; Borda A; Radulescu D; Puscasiu L; Berger N; Nogales FF
Pathol Res Pract; 2007; 203(11):819-22. PubMed ID: 17905525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
